المؤلفون: William Leung, Nisha Nair, Giorgi Kvizhinadze, Tony Blakely

المصدر: PLoS Medicine
PLoS Medicine, Vol 13, Iss 8, p e1002067 (2016)

مصطلحات موضوعية: Oncology, Economics, Cost-Benefit Analysis, Cancer Treatment, lcsh:Medicine, Estrogen receptor, Social Sciences, 0302 clinical medicine, Trastuzumab, Breast Tumors, Medicine and Health Sciences, 030212 general & internal medicine, Epidermal growth factor receptor, Aged, 80 and over, biology, Pharmaceutics, Age Factors, General Medicine, Health Care Costs, Middle Aged, Prognosis, Markov Chains, Receptors, Estrogen, Hormone receptor, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, Receptors, Progesterone, medicine.drug, Research Article, Clinical Oncology, Adult, medicine.medical_specialty, Death Rates, Cost-Effectiveness Analysis, Breast Neoplasms, 03 medical and health sciences, Breast cancer, Health Economics, Drug Therapy, Population Metrics, Diagnostic Medicine, Internal medicine, Progesterone receptor, Breast Cancer, medicine, Chemotherapy, Humans, Demography, Aged, Population Biology, business.industry, lcsh:R, Cancer, Cancers and Neoplasms, Biology and Life Sciences, Genes, erbB-2, medicine.disease, Economic Analysis, Health Care, Regimen, Age Groups, People and Places, biology.protein, Quality of Life, Population Groupings, Clinical Medicine, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2957b19196db1dbdd54ef62dae0a75c5
http://europepmc.org/articles/PMC4978494